Key result
Hospitalization for COVID-19 was associated with a 0.6% incidence of 30-day readmission due to myocardial infarction.
Why the study?
Does hospitalization for COVID-19 expose patients to a significant risk of 30-day readmission due to myocardial infarction?
Does hospitalization for COVID-19 expose patients to a significant risk of 30-day readmission due to myocardial infarction?
Answers are grounded in this paper and cite their sources.
Although the absolute incidence of 30-day post-discharge MI is relatively low at 0.6%, the massive population-level scale of COVID-19 infections makes this a highly relevant downstream cardiovascular complication.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kosyakovsky et al. (2023) conducted an editorial in COVID-19 hospitalization (n=521,351). COVID-19 hospitalization was evaluated on 30-day readmission due to myocardial infarction. Hospitalization for COVID-19 was associated with a 0.6% incidence of 30-day readmission due to myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: